BeOne Medicines ONC
NASDAQ ONC
$374.47 +5.31 (+1.44%)
At close: Aug 21, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Amortizatization of Intangibles (2018 - 2019)

BeOne Medicines (ONC) posted quarterly Amortizatization of Intangibles of -$51000.0 for Q3 2019, up 98.85% year-over-year from -$25647.3 in Q3 2018, and up 95.9% quarter-over-quarter from -$1.2 million in Q2 2019.

BeOne Medicines (ONC) Amortizatization of Intangibles (2018 - 2019) Analysis & Trends

BeOne Medicines (ONC) has reported Amortizatization of Intangibles for 2 consecutive years, with -$51000.0 the latest figure, recorded in Q3 2019.

  • In Q3 2019, Amortizatization of Intangibles rose 98.85% year-over-year to -$51000.0; the TTM figure through Sep 2019 stood at -$7.3 million (down 64.29% YoY), while the FY2018 annual figure was -$8.0 million, changed N/A from the prior year.
  • Amortizatization of Intangibles grew to -$51000.0 in Q3 2019 per ONC's latest filing, from -$1.2 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at -$51000.0 in Q3 2019 and bottomed at -$4.4 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Roivant Sciences 26.20 Bn 26.20 Bn 1.16 Mn 1.39 Mn

Historic Data

Download Data
DateValue
Sep 30, 2019 -51,000.00
Sep 30, 2019 -51,000.00
Jun 30, 2019 -1.24 Mn
Jun 30, 2019 -1.24 Mn
Mar 31, 2019 -2.41 Mn
Mar 31, 2019 -2.41 Mn
Dec 31, 2018 -3.59 Mn
Dec 31, 2018 -3.59 Mn
Sep 30, 2018 -4.44 Mn
Sep 30, 2018 -4.44 Mn